Eagle Pharmaceuticals Inc 401(K) Profit Sharing Plan & Trust — Form 5500 plan (Eagle Pharmaceuticals Inc)
Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Eagle Pharmaceuticals Inc 401(K) Profit Sharing Plan & Trust is a benefit plan reported by Eagle Pharmaceuticals Inc under EIN 20-8179278 and plan number 001. The latest loaded filing year is 2023. The filing reports 188 participants and $15,913,040 in end-of-year plan assets, where available in the loaded dataset.
Key reported metrics
- Plan sponsor
- Eagle Pharmaceuticals Inc
- EIN
- 20-8179278
- Plan number
- 001
- Plan type
- 2
- Location
- Woodcliff Lake, NJ
- Latest filing year
- 2023
- Participants
- 188
- End-of-year plan assets
- $15,913,040
Form 5500 filing history
| Filing year | Participants | Schedules | Filing |
|---|---|---|---|
| 2023 | 188 | H, C | 20241015160226NAL0030269585001 |
Reported financial statement (2023 · Schedule H)
Net assets
- Total assets (EOY)
- $15,913,040
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $15,913,040
- Net assets (BOY)
- $12,991,361
Income & contributions
- Employer contributions
- $1,177,502
- Participant contributions
- $2,572,058
- Total contributions
- $4,131,218
- Total income / additions
- $6,649,218
Expenses & distributions
- Benefits paid
- $3,670,874
- Administrative expenses
- $53,435
- Total expenses
- $3,727,539
- Net increase / (decrease)
- $2,921,679
Service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. | Year |
|---|---|---|---|---|
| Merrill Lynch, Pierce, Fenner | INVESTMENT ADVISORY PLAN | $34,963 | not reported in the loaded dataset | 2023 |
| Paychex, Inc. | RECORDKEEPER | $13,725 | not reported in the loaded dataset | 2023 |